PURPOSE: The aim of the present study was to compare maternal serum and cord blood irisin levels in females whose pregnancies were or were not complicated by idiopathic foetal growth restriction. METHODS: A total of 30 subjects participated. The study group consisted of 15 female patients who were referred to our perinatology clinic for delivery because of foetal growth restriction developing in the third trimester. Fifteen females with uncomplicated singleton pregnancies constituted the control group. Irisin levels were assessed in maternal serum, as well as in serum from the umbilical vein and artery. RESULTS: The demographic features of the two groups were similar (p > 0.05). Gestational age at delivery and birth weight were higher in females with uncomplicated pregnancies (p = 0.001). Umbilical artery irisin levels were significantly lower in pregnancies complicated by foetal growth restriction compared to controls (p = 0.003). Umbilical artery irisin levels were positively correlated with foetal weight (p = 0.01) and foetal abdominal circumference (measured by ultrasonography) (p = 0.01). Maternal and umbilical vein irisin levels did not differ between the two groups (p > 0.05). CONCLUSIONS: The data suggest that umbilical artery irisin levels were lower in pregnancies complicated by foetal growth restriction. Such lower irisin levels may contribute to the pathogenesis of this common condition, and metabolic syndrome may be a long-term consequence of idiopathic FGR.
PURPOSE: The aim of the present study was to compare maternal serum and cord blood irisin levels in females whose pregnancies were or were not complicated by idiopathic foetal growth restriction. METHODS: A total of 30 subjects participated. The study group consisted of 15 female patients who were referred to our perinatology clinic for delivery because of foetal growth restriction developing in the third trimester. Fifteen females with uncomplicated singleton pregnancies constituted the control group. Irisin levels were assessed in maternal serum, as well as in serum from the umbilical vein and artery. RESULTS: The demographic features of the two groups were similar (p > 0.05). Gestational age at delivery and birth weight were higher in females with uncomplicated pregnancies (p = 0.001). Umbilical artery irisin levels were significantly lower in pregnancies complicated by foetal growth restriction compared to controls (p = 0.003). Umbilical artery irisin levels were positively correlated with foetal weight (p = 0.01) and foetal abdominal circumference (measured by ultrasonography) (p = 0.01). Maternal and umbilical vein irisin levels did not differ between the two groups (p > 0.05). CONCLUSIONS: The data suggest that umbilical artery irisin levels were lower in pregnancies complicated by foetal growth restriction. Such lower irisin levels may contribute to the pathogenesis of this common condition, and metabolic syndrome may be a long-term consequence of idiopathic FGR.
Authors: H L Galan; S Rigano; T Radaelli; I Cetin; M Bozzo; J Chyu; J C Hobbins; E Ferrazzi Journal: Am J Obstet Gynecol Date: 2001-10 Impact factor: 8.661
Authors: Magnus Kaijser; Anna-Karin Edstedt Bonamy; Olof Akre; Sven Cnattingius; Fredrik Granath; Mikael Norman; Anders Ekbom Journal: Circulation Date: 2008-01-02 Impact factor: 29.690
Authors: Jian-Jun Liu; Melvin D S Wong; Wan Ching Toy; Clara S H Tan; Sylvia Liu; Xiao Wei Ng; Subramaniam Tavintharan; Chee Fang Sum; Su Chi Lim Journal: J Diabetes Complications Date: 2013-04-22 Impact factor: 2.852
Authors: Arturo Roca-Rivada; Cecilia Castelao; Lucía L Senin; María O Landrove; Javier Baltar; Ana Belén Crujeiras; Luisa María Seoane; Felipe F Casanueva; María Pardo Journal: PLoS One Date: 2013-04-11 Impact factor: 3.240
Authors: Marta G Novelle; Cristina Contreras; Amparo Romero-Picó; Miguel López; Carlos Diéguez Journal: Int J Endocrinol Date: 2013-11-05 Impact factor: 3.257
Authors: Eileen I Chang; Paul J Rozance; Stephanie R Wesolowski; Leanna M Nguyen; Steven C Shaw; Robert A Sclafani; Kristen K Bjorkman; Angela K Peter; William Hay; Laura D Brown Journal: J Endocrinol Date: 2019-12-19 Impact factor: 4.286